A bill for an act relating to the ordering, administering, and dispensing of point-of-care HIV-related tests and prophylaxis drugs by a pharmacist.

2025-2026 Regular Session Introduced by Jerome Amos and 9 co-sponsors

HF 183 empowers pharmacists to order and dispense HIV tests and prevention drugs, improving access to care for at-risk individuals and enhancing public health outcomes.

Introduced, referred to Commerce.

#hiv/aids #medicalcare #pharmacy #prescriptiondrugs

Overview

Bill Number: HF 183
Title: A bill for an act relating to the ordering, administering, and dispensing of point-of-care HIV-related tests and prophylaxis drugs by a pharmacist.
Status: Introduced, referred to Commerce
Introduced Date: January 30, 2025
Classification: Bill
Subject Areas: HIV/AIDS, Medical Care, Pharmacy, Prescription Drugs

Purpose and Intent

The primary intent of HF 183 is to expand the role of pharmacists in the healthcare system by allowing them to order, administer, and dispense HIV-related tests and prophylaxis drugs. This initiative aims to enhance access to HIV prevention and treatment services, particularly in communities where healthcare resources may be limited.

Key Provisions

Pharmacist Authority: The bill grants pharmacists the authority to order and administer both HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).

Health Benefit Plans: It mandates that health benefit plans must provide payment or reimbursement for services rendered by pharmacists when these services fall within the lawful scope of practice and are conducted under a statewide protocol established by the bill.

Definitions: The bill includes specific definitions for key terms such as:

Health Benefit Plan
Health Carrier
HIV
HIV-related Test

Impact

Pharmacists: This bill would significantly enhance the role of pharmacists in managing HIV prevention and treatment, potentially increasing the number of individuals who receive necessary services.

Patients: Individuals at risk for or living with HIV would benefit from improved access to testing and prophylactic treatments, which could lead to better health outcomes and reduced transmission rates.

Healthcare System: By leveraging pharmacists' capabilities, the bill aims to alleviate some of the burdens on primary care providers and improve overall public health responses to HIV.

Procedural Aspects

The bill was introduced on January 30, 2025, and has been referred to the Commerce committee for further consideration. The timeline for subsequent legislative actions will depend on the committee's schedule and deliberations.

In summary, HF 183 seeks to empower pharmacists in the fight against HIV by allowing them to provide critical testing and preventive services, thereby improving access and potentially enhancing public health outcomes.

Bill